Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea - Wikidata - awgldk - TriplyDB

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

http://www.wikidata.org/entity/Q26853285

about

Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.Recent advances in the diagnosis of irritable bowel syndrome.Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation

P2860

Q26769635-14084177-A175-4FD6-9A1E-2A4D2556177F Q35817782-BFED66D7-4F28-4263-8D8F-C5FE3C6260B8 Q36021269-048ADD64-D236-4EA4-A243-AB25EEDEFD75 Q38545062-D69F0781-C222-4BED-8C33-5D2C7F281C6E Q38810529-1279AD19-8AF8-49AB-A6A7-3189675D42B7 Q38988993-253F0FC2-58A7-4CC9-AFC5-FC895D3D61C2 Q57490211-5F053AF8-DF6A-46BD-AD71-3A62EE03A092

P2860

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

http://www.wikidata.org/entity/Q26853285

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@ast

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@en

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@nl

type

label

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@ast

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@en

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@nl

prefLabel

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@ast

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@en

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@nl

P1433

Q26853285-D5CA7BE3-9FFB-4B80-8B58-D8C87F2B37BF

P1476

Q26853285-F79DDBB8-67DA-4289-9C48-D7D4B88CB19E

P2860

Q26853285-04805ED9-E843-4E15-850F-88930F2AB975

Q26853285-05CFDEF3-5B00-484F-8BA3-A2EB84112572

Q26853285-15AF07FE-AE68-4BF0-BBF7-22A7CCC26745

Q26853285-1852CE82-ACC6-4D23-88A2-395B12F792CA

Q26853285-1CAB6A8B-4414-4B17-8C37-45DA3B2FF162

Q26853285-1E00259D-2900-4249-9E2A-3FF60E179FFF

Q26853285-2001D50E-BAD1-4261-A3B4-D30F084376E6

Q26853285-22C06D42-EAD5-4F2A-B04B-46F6E766555A

Q26853285-2366A0C6-8CF5-4219-A778-B27CFF1F456F

Q26853285-288C5710-B18A-43DD-8F06-043FA12DF53A

P304

Q26853285-F93A2422-07D4-44FB-9EA5-7A79F8C5B8F8

P31

Q26853285-55B3BEE2-C253-46F5-9F00-8DD7F75ABF34

P356

Q26853285-FBF9C276-5147-4366-BBB0-3BCF1306D6C4

P407

Q26853285-6806D708-1A57-4F08-B68E-6D8CC2214D87

P433

Q26853285-DB56EC27-EE2D-4E57-BE5B-82CA993D37E6

P478

Q26853285-75C2B906-13CA-4054-B7E3-39D55F5D5C54

P50

Q26853285-CF593183-D463-4997-B208-0CAB7985EEE0

P577

Q26853285-5AFC53BF-454A-41B9-9D58-CF1FE730802A

P5875

Q26853285-F133340E-E2B4-49BF-98CF-B95ED2C726FE

P698

Q26853285-0E79B0BA-BFC1-4F83-B84C-96DC454BE66C

P921

Q26853285-EE378AEA-9BE5-459D-817B-B30D024E2EA3

P932

Q26853285-51DB1417-82E7-42F3-8E87-B6C15FB32A56

P356

J.CGH.2014.07.020

P1433

Clinical Gastroenterology and Hepatology

P1476

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea

@en

P2860

A G protein-coupled receptor responsive to bile acids

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation

Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis

Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.

P304

1051-7; quiz e61-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2014.07.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264093162

http://www.w3.org/2001/XMLSchema#string

P698

25041862

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

4297594

http://www.w3.org/2001/XMLSchema#string